Jeremie Boucher

Cardiovascular, Renal and Metabolism department

AstraZeneca; Wallenberg Center for Molecular and Translational Medicine

Jeremie Boucher
Principal Scientist

Jeremie Boucher is Principal Scientist in the Cardiovascular, Renal, and Metabolism department at AstraZeneca in Gothenburg, Sweden. He is also adjunct senior lecturer and has a research group as part of the Wallenberg Center for Molecular and Translational Medicine at the University of Gothenburg.

Dr Boucher did his post-doctoral training in Ron Kahn’s laboratory at the Joslin Diabetes Center, Harvard University, Boston, USA. There he studied the differences between insulin and IGF-1 signaling, and the role of insulin and IGF-1 receptors in the control of gene regulation, apoptosis, and white and brown fat development and function. Dr Boucher’s current research interests include the modulation of adipose tissue health and function for the treatment of metabolic diseases.

Publications

Isolement et culture des adipocytes matures humains utilisant les cultures agrégées d’adipocytemûr mûr de membrane (MAAC)

1Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 2The Lundberg Laboratory for Diabetes Research, University of Gothenburg, 3Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg

JoVE 60485

 Biology